MX9803554A - Derivados de tropano fusionados, su preparacion y uso. - Google Patents
Derivados de tropano fusionados, su preparacion y uso.Info
- Publication number
- MX9803554A MX9803554A MX9803554A MX9803554A MX9803554A MX 9803554 A MX9803554 A MX 9803554A MX 9803554 A MX9803554 A MX 9803554A MX 9803554 A MX9803554 A MX 9803554A MX 9803554 A MX9803554 A MX 9803554A
- Authority
- MX
- Mexico
- Prior art keywords
- alkyl
- alkynyl
- alkenyl
- aryl
- arylalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Exhaust Gas After Treatment (AREA)
Abstract
La presente invencion describe un compuesto de la formula (Ver Formula) o cualquiera de sus enantiomeros o cualquier mezcla del mismo, una sal de adicion farmacéuticamente aceptable del mismo, o el N-oxido del mismo, caracterizado porque X y Y forman juntos =0, =S, =NOR2, -CR3R4, =N-CN, =N-NR7R8, (CH2)m- o -W'-(CH2)p-W", o uno de X y Y es hidrogeno y el otro es -OR5, -SR5, o -NR5R6 Z es hidrogeno, -COOR9; R3 y R4 son independientemente hidrogeno, halogeno, alquilo, cicloalquilo, cicloalquilalquilo, alquenilo, alquinilo, alcoxi, arilo, arilalquilo o -(CH2)4-COOR2; R2, R5 y R6 son independientemente hidrogeno, alquilo, cicloalquilo, cicloalquilalquilo, alquenilo, alquinilo, arilo o arilalquilo, -co-alquilo o -SO2-alquilo; R7 y R8 son independientemente hidrogeno, alquilo, cicloalquilo, cicloalquilalquilo, alquenilo, alquinilo, arilo o arilalquilo; R9 es alquilo, alquenilo o alquinilo; R1 es alquilo, alquenilo, alquinilo, arilo o arilaquilo; en donde dichos grupos arilo pueden ser substituidos una o más veces con substituyentes seleccionados del grupo que consiste de halogeno; CF3, CN, alcoxi, cicloalcoxi, alquilo, cicloalquilo, alquenilo, alquinilo, amino, alquilamino, dialquilamino y nitro; W' y W" son cada uno independientemente O o S; n es 1,2,3 o 4; m es 2,3,4 o 5; p es 1,2,3,4 o 5; y d es 0,1,2,3 o 4.; los compuestos poseen propiedades valiosas como neurotransmisor de monoamina, es decir, inhibidores de la recaptacion de dopamina y serotonina.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK122395 | 1995-11-02 | ||
| DK1223/95 | 1995-11-02 | ||
| DK14696 | 1996-02-13 | ||
| DK0146/96 | 1996-02-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX9803554A true MX9803554A (es) | 1998-09-30 |
| MXPA98003554A MXPA98003554A (es) | 1998-11-16 |
Family
ID=
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2236707A1 (en) | Fused tropane-derivatives, their preparation and use | |
| UA49872C2 (uk) | Похідні тропану, спосіб їх одержання, фармацевтична композиція та спосіб лікування | |
| ATE362931T1 (de) | 8-azabicyclo(3.2.1)oct-2en-derivate, deren herstellung und anwendung | |
| MY114679A (en) | Aroyl-piperidine derivatives | |
| UA49801C2 (uk) | Похідні тропан-2-альдоксиму, спосіб їх отримання, фармацевтична композиція, спосіб лікування | |
| JO2235B1 (en) | Derivatives of phenyl | |
| DE69817557D1 (de) | Piperidine derivate als inhibitoren der neurotransmitter-wiederaufbaunahme | |
| AU3327399A (en) | Benzisoxazole derivatives having d4-antagonistic activity | |
| HUP9802568A2 (hu) | Glutamát-receptor antagonista hatású szubsztituált-kinoxalin-2,3-dionok alkil-amin-származékai és ezeket tartalmazó gyógyszerkészítmények | |
| EP1116486A4 (en) | MEDICAL COMPOSITION CONTAINING NITROETHENAMINE DERIVATIVES OR SALTS AS ACTIVE INGREDIENTS |